Growth Metrics

Oscar Health (OSCR) Liabilities and Shareholders Equity (2020 - 2025)

Oscar Health's Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $6.3 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 30.68% year-over-year to $6.3 billion; the TTM value through Dec 2025 reached $24.3 billion, up 29.61%, while the annual FY2025 figure was $6.3 billion, 30.68% up from the prior year.
  • Liabilities and Shareholders Equity reached $6.3 billion in Q4 2025 per OSCR's latest filing, up from $5.7 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.4 billion in Q2 2025 to a low of $3.2 billion in Q3 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $4.5 billion, with a median of $4.5 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 46.19% in 2021, then fell 22.26% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.3 billion in 2021, then skyrocketed by 36.28% to $4.5 billion in 2022, then fell by 20.44% to $3.6 billion in 2023, then surged by 34.4% to $4.8 billion in 2024, then skyrocketed by 30.68% to $6.3 billion in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Liabilities and Shareholders Equity are $6.3 billion (Q4 2025), $5.7 billion (Q3 2025), and $6.4 billion (Q2 2025).